Current Report Filing (8-k)
December 17 2015 - 6:31AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The
Securities Exchange Act of 1934
December
17, 2015 (December 16, 2015)
Date
of Report (Date of earliest event reported)
IMS Health Holdings, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-36381
|
|
27-1335689
|
(State or other
jurisdiction
of incorporation)
|
|
(Commission File
Number)
|
|
(I.R.S. Employer
|
|
|
|
Identification No.)
|
83 Wooster Heights Road
Danbury, CT 06810
(Address
of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (203)
448-4600
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
⃞
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
⃞
|
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
|
⃞
|
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Events.
On December 16, 2015, the Board of Directors of IMS Health Holdings,
Inc. (the “Company”) approved a stock repurchase program (the
“Repurchase Program”), authorizing the repurchase of up to $250 million
of its common stock. The Repurchase Program does not obligate the
Company to repurchase any particular amount of common stock, and it
could be modified, suspended or discontinued at any time. The timing and
amount of repurchases are determined by the Company’s management at its
discretion based on a variety of factors such as the market price of its
common stock, corporate requirements, general market and economic
conditions, legal requirements and compliance with the terms of the
Company's senior secured credit facilities and the indentures governing
its outstanding senior notes. Purchases of the Company’s common stock
may be made in open market transactions effected through a broker-dealer
at prevailing market prices, in block trades, in privately negotiated
transactions or by other means in accordance with federal securities
laws. The Repurchase Program does not have a specified expiration date.
On December 17, 2015, the Company issued a press release announcing the
share repurchase authorization. The full text of the press release is
attached hereto as exhibit 99.1 and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit No.
|
|
Description of Document
|
|
|
|
99.1
|
|
Press release, dated December 17, 2015, on share repurchase
authorization.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
IMS HEALTH HOLDINGS, INC.
|
|
|
|
|
By:
|
/s/ Ronald E. Bruehlman
|
|
Name:
|
Ronald E. Bruehlman
|
|
Title:
|
Senior Vice President and
Chief Financial Officer
|
Dated: December 17, 2015
|
|
|
EXHIBIT INDEX
Exhibit
No.
|
|
Description of Document
|
|
|
|
99.1
|
|
Press release, dated December 17, 2015, on share repurchase
authorization.
|
Exhibit 99.1
IMS
Health Announces $250 Million Share Repurchase Authorization
DANBURY, Conn.--(BUSINESS WIRE)--December 17, 2015--IMS Health Holdings,
Inc. (NYSE:IMS) today announced that its board of directors approved a
stock repurchase program authorizing the repurchase of up to $250
million of its common stock.
The share repurchase program does not obligate the company to repurchase
any particular amount of common stock, and it could be modified,
suspended or discontinued at any time. The timing and amount of
repurchases are determined by IMS Health’s management at its discretion
based on a variety of factors such as the market price of its common
stock, corporate requirements, general market and economic conditions,
legal requirements and compliance with the terms of the company’s senior
secured credit facilities and the indentures governing its outstanding
senior notes. Purchases of the company’s common stock may be made in
open market transactions effected through a broker-dealer at prevailing
market prices, in block trades, in privately negotiated transactions or
by other means in accordance with federal securities laws. The share
repurchase program does not have a specified expiration date.
About IMS Health
IMS Health is a leading global information and technology services
company providing clients in the healthcare industry with end-to-end
solutions to measure and improve their performance. Our 7,500 services
experts connect configurable SaaS applications to 10+ petabytes of
complex healthcare data in the IMS One™ cloud platform,
delivering unique insights into diseases, treatments, costs and
outcomes. The company’s 15,000 employees blend global consistency and
local market knowledge across 100 countries to help clients run their
operations more efficiently. Customers include pharmaceutical, consumer
health and medical device manufacturers and distributors, providers,
payers, government agencies, policymakers, researchers and the financial
community.
As a global leader in protecting individual patient privacy, IMS Health
uses anonymous healthcare data to deliver critical, real-world disease
and treatment insights. These insights help biotech and pharmaceutical
companies, medical researchers, government agencies, payers and other
healthcare stakeholders to identify unmet treatment needs and understand
the effectiveness and value of pharmaceutical products in improving
overall health outcomes. Additional information is available at www.imshealth.com.
IMSFIN
CONTACT:
IMS Health Holdings, Inc.
Tom Kinsley, +1.203.448.4691
Investor
Relations
tkinsley@imshealth.com
or
Tor Constantino,
+1.484.567.6732
Media Relations
tconstantino@us.imshealth.com
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jul 2023 to Jul 2024